RxDoctor Payments Data

Chad Boomershine

Rheumatology · Nashville, TNNPI 1457408304

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,030 of the $9,700 with a category attached, or 82.8%. 24 manufacturers reported payments, led by Pfizer at 46.3% of the total. Reporting peaked in 2019 at $4,912 and has fallen 99.7% since, to $16 in 2023.

$9,700in general payments, 2019–2025

Across 73 payments — averaging $132.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • Regeneron$4K
  • UCB, Inc.$282
  • Amgen$163
  • Regeneron Healthcare Solutions, Inc.$121
  • AbbVie$118
  • plus $649 from 18 others
$94,970in research payments, 2019–2025

Across 24 payments — averaging $3957.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$85K
  • Shionogi Inc$5K
  • Pfizer$2K
  • Amgen$2K
  • Regeneron$333

What the payments were for

  • Consulting fees$8,03083%
  • Travel & lodging$3373%
  • Food & beverage$1,31814%
  • Education$150%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,700 in reported general payments places this provider in the 65th percentile of 127 rheumatology providers in Tennessee.

See all rheumatology providers in Tennessee →

Other rheumatology in Nashville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →